PALI
Palisade Bio Inc
1.40$
+0.7%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -17.7% | -10.0% | +1.7% | -27.5% | +16.5% | -24.7% | -18.6% | +4.6% | +1,826.6% | -0.8% | -4.5% | |
| – | -18.1% | -9.9% | +2.5% | -28.0% | +18.3% | -24.8% | -18.3% | +5.9% | +1,865.7% | -0.7% | -4.5% | |
| – | -18.8% | -9.3% | +0.7% | -29.2% | +22.2% | -26.4% | -25.1% | -3.5% | +2,451.8% | -0.6% | -5.6% | |
| – | -18.8% | -9.3% | +0.7% | -29.2% | +22.2% | -26.4% | -25.1% | -3.5% | +2,451.8% | -0.6% | -5.6% | |
| – | +9.6% | +3.4% | -16.3% | -25.0% | -75.0% | +225.0% | -92.3% | +200.0% | +1,366.7% | -96.6% | +5,455.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -8.2% | -5.5% | +12.9% | -6.6% | +24.2% | -15.6% | +41.6% | -7.1% | +32.0% | +19.9% | -6.5% | |
| – | -2.4% | -4.6% | +15.0% | -5.5% | +20.7% | -14.2% | +43.0% | -12.4% | +33.3% | +21.2% | -6.7% | |
| – | -25.8% | -55.2% | +283.2% | -25.5% | -52.7% | -65.7% | +482.8% | -37.6% | -66.4% | – | – | |
| – | -46.6% | -21.5% | -6.2% | -28.8% | +231.7% | -22.4% | +89.5% | -20.1% | -34.8% | +189.9% | -31.9% | |
| – | -19.7% | -11.0% | -1.1% | -33.6% | +13.4% | -28.8% | -50.9% | +22.6% | +3,928.0% | -1.6% | -4.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +1,792.9% | +36.3% | -53.9% | +0.0% | +46.8% | -43.8% | +0.0% | +55.8% | +644.9% | +276.6% | +0.8% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.